Cargando…
MicroRNA-Based Therapeutics for Drug-Resistant Colorectal Cancer
Although therapeutic approaches for patients with colorectal cancer (CRC) have improved in the past decades, the problem of drug resistance still persists and acts as a major obstacle for effective therapy. Many studies have shown that drug resistance is related to reduced drug uptake, modification...
Autores principales: | Jung, Eunsun, Choi, Jinhyeon, Kim, Jang-Seong, Han, Tae-Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915952/ https://www.ncbi.nlm.nih.gov/pubmed/33567635 http://dx.doi.org/10.3390/ph14020136 |
Ejemplares similares
-
MicroRNA-1258 Inhibits the Proliferation and Migration of Human Colorectal Cancer Cells through Suppressing CKS1B Expression
por: Hwang, Jin-Seong, et al.
Publicado: (2019) -
The EDN1/EDNRA/β-arrestin axis promotes colorectal cancer progression by regulating STAT3 phosphorylation
por: Lee, Yeo-Jin, et al.
Publicado: (2022) -
MicroRNA-in drug resistance
por: Li, Haoran, et al.
Publicado: (2014) -
Unique Behavioral Characteristics and microRNA Signatures in a Drug Resistant Epilepsy Model
por: Moon, Jangsup, et al.
Publicado: (2014) -
The Role of Exosomal microRNA in Cancer Drug Resistance
por: Guo, Qiao-ru, et al.
Publicado: (2020)